Michelle Kim-Danely

Michelle Kim-Danely PhD is a seasoned strategic builder and advisor in the life sciences sector, currently serving as a Strategic Builder at Stealth since June 2024. With extensive experience spanning multiple startups and venture capital firms since 2017, Michelle collaborates with CEOs and investors on scientific and technical diligence, corporate development, and innovative topics such as prescription digital therapeutics and novel gene therapies. Previous roles include Interim Chief Development Officer at ALPHA10X, SVP Operations at Autobahn Labs, and VP of Business Development at Biodesy, where Michelle led significant initiatives and partnerships. An alumnus of Columbia University with a PhD in Biochemistry and Molecular Biophysics, and Cornell University, Michelle possesses a robust foundation in biological sciences and a proven track record in driving strategic growth and innovation within the life sciences industry.